XML 14 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Collaboration revenue [1] $ 148 $ 211,928 $ 349 $ 212,574
Operating expenses:        
Research and development [2] 71,008 57,246 184,581 130,601
General and administrative 21,539 15,519 62,442 46,216
Total operating expenses 92,547 72,765 247,023 176,817
Income (loss) from operations (92,399) 139,163 (246,674) 35,757
Other income (expense):        
Loss from equity method investment   (3,430)   (5,467)
Other income, net 160 2,964 5,804 6,470
Total other income (expense), net 160 (466) 5,804 1,003
Net income (loss) before income taxes (92,239) 138,697 (240,870) 36,760
Provision for income taxes (200) (274) (956) (444)
Net income (loss) (92,439) 138,423 (241,826) 36,316
Foreign currency translation adjustment 31 (12) 3 (14)
Unrealized loss on marketable securities (144)   (144)  
Comprehensive income (loss) $ (92,552) $ 138,411 $ (241,967) $ 36,302
Net income (loss) per common share — basic $ (1.32) $ 2.52 $ (3.77) $ 0.68
Basic weighted-average common shares outstanding 70,143,481 54,829,057 64,159,224 53,380,123
Net income (loss) per common share — diluted $ (1.32) $ 2.40 $ (3.77) $ 0.65
Diluted weighted-average common shares outstanding 70,143,481 57,598,901 64,159,224 55,821,420
[1] Including the following revenue from a related party, see Notes 7 & 12
[2] Including the following research and development expense with a related party, see Notes 7 & 12